Stocks · Health care · Pharmaceutical Preparations

IRONWOOD PHARMACEUTICALS INC

IRWD Clue Score47
United States Fiscal year ends December CIK 0001446847 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

17 insiders · 0 transactions
9.8×

Thomas McCourt holds 9.8 times base salary in stock. $8.58M of shares against $867.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas McCourt last reported holding, valued at $4.52, the price Class A Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Alexander J Denner
Director
—
—
—
9,516,184
$43.01M
−40.8%
Thomas A MCCOURT
Chief Executive Officer
—
—
—
1,898,838
$8.58M
+64.8%
Michael Shetzline
SVP, CMO, Head-Res&Drug
—
—
—
1,179,462
$5.33M
+30.9%
Ronald Silver
PFO & PAO
—
—
—
755,250
$3.41M
+18.9%
Mark G Currie
Director
—
—
—
676,900
$3.06M
+19.1%
Minardo John
Chief Legal Officer
—
—
—
500,498
$2.26M
+75.8%
Tammi L Gaskins
Chief Commercial Officer
—
—
—
350,350
$1.58M
+42.9%
Sravan Kumar Emany
SVP, COO and CFO
—
—
—
309,572
$1.40M
−3.4%
Gregory S. Martini
Chief Financial Officer
—
—
—
297,213
$1.34M
+250.7%
Andrew Davis
SVP, Chief Business Officer
—
—
—
284,685
$1.29M
−1.8%
Jon R Duane
Director
—
—
—
253,820
$1.15M
+74.6%
Julie McHugh
Director
—
—
—
250,749
$1.13M
+53.0%
Jay Shepard
Director
—
—
—
235,036
$1.06M
+85.7%
Marla L Kessler
Director
—
—
—
229,364
$1.04M
+89.7%
Andrew Dreyfus
Director
—
—
—
228,313
$1.03M
+24.5%
Catherine Moukheibir
Director
—
—
—
181,425
$820.04K
+148.7%
Jeffrey Silber
SVP, CMO, Head-Res&Drug
—
—
—
137,036
$619.40K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.